372 related articles for article (PubMed ID: 16214223)
1. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients.
Suzuki Y; Onodera H; Tago H; Saito R; Ohuchi M; Shimizu M; Matsumura Y; Kondo T; Yoshie O; Itoyama Y
J Neuroimmunol; 2006 Mar; 172(1-2):166-74. PubMed ID: 16427705
[TBL] [Abstract][Full Text] [Related]
3. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
[TBL] [Abstract][Full Text] [Related]
4. Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression.
Rasheed AU; Rahn HP; Sallusto F; Lipp M; Müller G
Eur J Immunol; 2006 Jul; 36(7):1892-903. PubMed ID: 16791882
[TBL] [Abstract][Full Text] [Related]
5. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
Reinhardt C; Melms A
Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
[TBL] [Abstract][Full Text] [Related]
6. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
[TBL] [Abstract][Full Text] [Related]
7. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells.
Sommer N; Willcox N; Harcourt GC; Newsom-Davis J
Ann Neurol; 1990 Sep; 28(3):312-9. PubMed ID: 2241114
[TBL] [Abstract][Full Text] [Related]
8. B cells alter the phenotype and function of follicular-homing CXCR5+ T cells.
Ebert LM; Horn MP; Lang AB; Moser B
Eur J Immunol; 2004 Dec; 34(12):3562-71. PubMed ID: 15549776
[TBL] [Abstract][Full Text] [Related]
9. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
[TBL] [Abstract][Full Text] [Related]
10. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
Zhang J; Zhou WB; Wang HL; Guo SS
Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
[TBL] [Abstract][Full Text] [Related]
11. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
12. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
13. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
[TBL] [Abstract][Full Text] [Related]
14. [Role of the thymus in the physiopathology of myasthenia].
Eymard B; Berrih-Aknin S
Rev Neurol (Paris); 1995 Jan; 151(1):6-15. PubMed ID: 7676132
[TBL] [Abstract][Full Text] [Related]
15. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
[TBL] [Abstract][Full Text] [Related]
16. Altered intrathymic T-cell repertoire in human myasthenia gravis.
Truffault F; Cohen-Kaminsky S; Khalil I; Levasseur P; Berrih-Aknin S
Ann Neurol; 1997 Jun; 41(6):731-41. PubMed ID: 9189034
[TBL] [Abstract][Full Text] [Related]
17. Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma.
Zhang M; Zhou Y; Guo J; Li H; Tian F; Gong L; Wang X; Lan M; Li Z; Zhang W
Exp Neurol; 2014 Apr; 254():200-5. PubMed ID: 24518487
[TBL] [Abstract][Full Text] [Related]
18. TCR-Vbeta usage in the thymus and blood of myasthenia gravis patients.
Navaneetham D; Penn AS; Howard JF; Conti-Fine BM
J Autoimmun; 1998 Dec; 11(6):621-33. PubMed ID: 9878084
[TBL] [Abstract][Full Text] [Related]
19. Selectively frequent expression of CXCR5 enhances resistance to apoptosis in CD8(+)CD34(+) T cells from patients with T-cell-lineage acute lymphocytic leukemia.
Qiuping Z; Jie X; Youxin J; Qun W; Wei J; Chun L; Jin W; Yan L; Chunsong H; Mingzhen Y; Qingping G; Qun L; Kejian Z; Zhimin S; Junyan L; Jinquan T
Oncogene; 2005 Jan; 24(4):573-84. PubMed ID: 15580304
[TBL] [Abstract][Full Text] [Related]
20. Thymic lymphocytes in myasthenia gravis.
Birnbaum G; Tsairis P
Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
